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Abstract
Direct transmission of avian influenza viruses to mammals has become an increasingly investigated topic during the past
decade; however, isolates that have been primarily investigated are typically ones originating from human or poultry
outbreaks. Currently there is minimal comparative information on the behavior of the innumerable viruses that exist in the
natural wild bird host. We have previously demonstrated the capacity of numerous North American avian influenza viruses
isolated from wild birds to infect and induce lesions in the respiratory tract of mice. In this study, two isolates from
shorebirds that were previously examined in mice (H1N9 and H6N1 subtypes) are further examined through experimental
inoculations in the ferret with analysis of viral shedding, histopathology, and antigen localization via immunohistochemistry
to elucidate pathogenicity and transmission of these viruses. Using sequence analysis and glycan binding analysis, we show
that these avian viruses have the typical avian influenza binding pattern, with affinity for cell glycoproteins/glycolipids
having terminal sialic acid (SA) residues with a 2,3 linkage [Neu5Ac(a2,3)Gal]. Despite the lack of a2,6 linked SA binding,
these AIVs productively infected both the upper and lower respiratory tract of ferrets, resulting in nasal viral shedding and
pulmonary lesions with minimal morbidity. Moreover, we show that one of the viruses is able to transmit to ferrets via direct
contact, despite its binding affinity for a 2,3 linked SA residues. These results demonstrate that avian influenza viruses,
which are endemic in aquatic birds, can potentially infect humans and other mammals without adaptation. Finally this work
highlights the need for additional study of the wild bird subset of influenza viruses in regard to surveillance, transmission,
and potential for reassortment, as they have zoonotic potential.
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Introduction
The host and virulence range for avian influenza viruses (AIV)
continues to surprise, with numerous cases of direct transmission
from birds to mammals that result in a range of disease including
pneumonia, conjunctivitis, and occasionally systemic disease [1–
3]. Although transmission of AIV to humans resulting in disease
has been limited to poultry adapted viruses, there is evidence of
both direct transmission of AIV to other mammalian species [3–5]
and experimental evidence that numerous AIV hemagglutinin
(HA) subtypes can infect mammals [5–10]. However, there
remains a great void of knowledge regarding the capacity of
AIV to infect mammals, especially related to AIVs from the wild
bird reservoir. Human AIV infections have been limited to the
H5, H7, and H9 subtypes [2,11–14] and these viruses are of
concern because they have a pandemic potential if they become
highly transmissible in the human population. Recent studies have
demonstrated the high compatibility of avian and human in-
fluenza reassortants in vitro and in vivo and generation of viable
reassortants in vivo in ferrets, further raising the concern of the
natural generation of a pandemic strain [15–18]. Examining the
capacity of a spectrum of wild bird AIVs to infect mammals is
necessary to complete our understanding of AIV host range
restrictions and to better define potential risks of mammalian
infection and viral reassortment.
We have previously screened wild bird AIVs in a mouse model
and demonstrated their varying capacity to replicate in the lung of
mice, with some isolates exhibiting robust pulmonary replication
regardless of HA subtype and causing mild clinical disease [19].
Ferrets are a better model for influenza infection and transmission
in humans as they are naturally susceptible to the virus and have
a similar distribution of sialic acid glycans in the respiratory tract;
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38067they have also been used for numerous studies of AIV that have
resulted in human disease [20–22]. In this study, two wild bird
AIVs (H1N9 and H6N1 subtypes) that exhibited robust pulmo-
nary replication in mice were further studied in a ferret model to
better assess pathogenesis and transmission capacity in mammals.
Viral contributors to host range restriction and virulence of
AIVs in mammals have been demonstrated to be a multifactorial.
The interaction between the major viral glycoprotein, the
hemagglutinin (HA) and the host cell sialic acid receptors is
considered critical for establishing an influenza infection, and
species specific binding restrictions have been identified. Influenza
viruses of avian origin preferentially bind terminal sialic acids with
a a2,3 linkage located in cells in the gastrointestinal tract of birds
and on the ciliated cells and type II pneumocyte in the human
respiratory tract [23–28]. Conversely, human influenza viruses
exhibit preferential binding to terminal sialic acids with a a2,6 SA
linkage located most prominently on non-ciliated cells of the
human upper respiratory tract (nasopharynx and trachea)
[23,27,29–32]. It is thought that the receptor specificity of
influenza viruses is a large component of host restriction; where
in some AIV cases (H5, H7, and H9 subtypes), the viruses are able
to infect and cause disease in humans yet exhibit poor human to
human transmission [14,33–35].
The amino acid residues contributing to a2,3 versus a2,6 SA
binding specificity have been described for some viruses and
mutation analysis has shown some of these residues to be directly
involved with altering viral receptor specificity. In human H3
strains, amino acids Leu226 and Ser228 (H3 numbering) results in
a2,6 SA binding, where avian strains that preferentially bind a2,3
SA receptors exhibit a Gln226 and Gly228 amino acid sequence
[26,27,32,36]. Amino acid residues 138, 190, 194, and 225 (H3
numbering) have also been shown to be differentially conserved in
avian and human influenza viruses [32].
Here we examine the potential for infection and transmission of
an H1N9 (A/Ruddy Turnstone/DE/1171/02abbreviated H1N9)
and an H6N1 (A/Ruddy Turnstone/DE/892/02abbreviated
H6N1) AIV. Using sequence, in vitro binding, and glycan
microarray analysis we determined the receptor specificity of
these viruses. Using the ferret model, the most representative
animal model of human influenza virus infection, we performed in
vivo assessment of the potential for infection, replication, and
transmission of these viruses in mammals. Despite a dominant
a2,3 (avian) binding specificity we demonstrate that both of these
viruses replicate in both the upper and lower respiratory tract of
ferrets, inducing pulmonary lesions, but resulting in little
morbidity. Moreover, we demonstrate that one of these viruses
(H1N9) is able to transmit via direct contact, despite its dominant
avian a2,3 SA binding preference. These findings support the
recent findings of others [37] and taken together demonstrate that
AIV circulating in wild bird populations can transmit to mammals,
albeit not always causing clinical disease, and that transmissibility
of AIV to mammals is not restricted to specific subtypes (i.e. H5N1
or H7). Further investigation of these circulating AIVs is
warranted to better understand their zoonotic potential.
Results
Wild bird influenza viruses replicated in ferrets but
exhibited low virulence
Infection in H1N9 and H6N1 inoculated ferrets and in H1N9
contact ferrets was demonstrated with presence of virus in nasal
washes and seroconversion despite minimal clinical signs (Table 1).
Three ferrets infected with H6N1 had transient, mild weight loss
that was most prominent day 1 pi (Table 1), but two of these
ferrets took an additional two to six days to return to pre-infection
weight. In contrast, six out of seven ferrets infected with H1N9 had
mild weight loss most prominent at day 1 post inoculation (pi)
(Table 1) in which it took up to four days to return to pre-infection
weight. The average temperature of H1N9 and H6N1 inoculated
ferrets was most elevated on day 1 pi (Table 1). Direct contact
H1N9 ferrets had elevated temperatures that did correlate with
shedding of virus in nasal washes, while direct contact H6N1
ferrets, which did not become infected, had rare, inconsistent
temperature elevations. Sneezing was not observed in any group of
ferrets and all ferrets remained bright and alert through the
duration of the study. There were no statistically significant
differences in the total or differential leukocyte parameters for
group by day interactions. However, mean lymphocytes (mean+/
2standard error) decreased in both H6N1 (3.50+/20.06 pre
inoculation to 3.26+/20.06 day 1 pi) and H1N9 (3.76+/
20.06 pre inoculation to 3.61+/20.09 day 1 pi) inoculated
groups compared to the allantoic inoculated group (3.46+/
20.05 pre inoculation to 3.45+/20.06 day 1 pi) for day 1 pi,
and then increased for the H1N9 (4.06+/20.16 day 7 pi)
inoculated group compared to the allantoic inoculated group
(3.67+/20.11 day 7 pi) and remained elevated through day 18 pi
(Table S1).
Both H1N9 and H6N1 wild bird influenza viruses
replicated in the upper respiratory tract of ferrets
Both H1N9 and H6N1 demonstrated replication in the upper
respiratory tract of ferrets, evident by nasal washes and
immunohistochemistry (IHC). Although both H1N9 and H6N1
replicated in the nasal cavity, H1N9 replication was more robust,
reaching consistently higher titers than H6N1 for days 3 and 5 pi
with shedding occurring consistently longer (Figure 1A, B and
Table 1). Lesions of influenza infection were present in the nasal
turbinates of ferrets infected with H1N9 and H6N1 (Figure 2A),
however, only a single ferret in the H6N1 group (day 3 pi) had
lesions while nasal turbinates of all four ferrets infected with H1N9
had lesions (both days 3 and 7 pi). This correlates with the viral
titers obtained from nasal washes of these ferrets, as viral shedding
quickly declined over a short period of time in this group with
some ferrets shedding virus only up to day 3 pi (Figure 1). Lesions
in the nasal turbinates included infiltration of the submucosa with
mild to moderate numbers of lymphocytes with fewer plasma cells
and occasional submucosal edema on both days 3 and 7 pi, with
an increased amount of inflammation on day 7 pi for H1N9
(Figure 2A). The presence of influenza viral antigen was confirmed
by abundant strong intranuclear and frequent intracytoplasmic
staining on IHC for the nucleoprotein (NP) of influenza A in the
nasal turbinates epithelium (Figure 2B). Positive staining occurred
on day 3 pi in the nasal turbinates of ferrets that had lesions and
was not present by day 7 pi for both viruses.
Both H1N9 and H6N1 wild bird influenza viruses
replicated in the lower respiratory tract of ferrets
There was evidence of replication of both H1N9 and H6N1 in
the lung of inoculated ferrets, with similar histopathologic
progression of lesions for both viruses. Influenza was detected in
the lung for both viruses for all ferrets day 3 pi using virus isolation
in ECEs, but was not isolated for day 7 pi from the lung for either
group of ferrets (Table 2). For both viruses, histopathologic change
in the lung on day 3 pi was characterized by a small amount of
mucus admixed with neutrophils and macrophages within the
lumens of bronchi and large bronchioles with peribronchial
inflammation, primarily lymphocytes, that surrounded and
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PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e38067occasionally infiltrated peribronchial glands (Figure 2G). There
was positive intranuclear immunoreactivity against the NP of
influenza A in small numbers of bronchiolar cells in the lungs of
ferrets infected with H1N9 and H6N1 on day 3 pi (Figure 2F). No
influenza antigen was present via IHC in the lung of ferrets
infected with either of the two viruses on day 7 pi, supporting that
virus was cleared from the lung by that time point. Rare
peribronchiolar glands contained cellular debris and necrosis of
the glandular epithelium, with presence of influenza antigen in the
epithelial cells demonstrated via IHC on day 3 pi (Figure 2H).
Smaller bronchioles were frequently filled with neutrophils,
macrophages, and cellular debris and lined by a mixture of ectatic
and very plump epithelial cells, indicative of early repair after
previous epithelial damage (Figure 2D, E). Smaller bronchioles still
had intraluminal inflammatory exudate and epithelial regenera-
tion on day 7 pi. Peribronchiolar alveoli of affected bronchioles
were occasionally filled by macrophages, but notably, there were
minimal alveolar changes. Some pulmonary vessels had small
perivascular cuffs composed primarily of lymphocytes. On both
day 3 and day 7 pi for both viruses, the caudal lung lobes were
more affected in severity and extent than the cranial lung lobes.
Importantly, only segmental areas of the lung were affected in
ferrets inoculated with either virus, with some lung lobes in
individual ferrets having no histopathologic lesions at all. There
was evidence of viral replication in the trachea, with rare
neutrophils present in the epithelium for both H1N9 and H6N1
and rare positive intranuclear epithelial immunoreactivity for the
NP of influenza for one H1N9 inoculated ferret. Lung in the three
inoculated ferrets from repeat transmission studies was examined
microscopically at day 21 pi; these tissues had no significant
lesions, indicating that complete resolution of pulmonary damage
and inflammation had occurred by this time.
As there was evidence of pulmonary damage with regeneration,
we suspected that viral replication in the lung had already peaked
by day 3 pi. A titer could not be obtained for the lung via TCID50
assay for day 3 pi for either virus (limit of detection=1.3 or 1.0
log10 TCID50/g) despite positive virus isolation. Therefore, two
additional ferrets were inoculated with H1N9 and lung examined
at day 2 pi. In the day 2 pi ferret lung, a virus titer was obtained
using a 1:3 dilution scheme (Table 1). Histopathologic changes in
the lung on day 2 pi also confirmed suspicion of early viral
replication, damage, and clearance, as the affected bronchiolar
epithelium had necrosis and sloughing without indication of the
regeneration that was observed on day 3 pi (Figure 2C). Positive
intranuclear immunoreactivity against the NP of influenza A was
also observed in small numbers of bronchiolar cells in the lungs for
day 2 pi.
Extra-respiratory detection of wild bird influenza viruses
in ferrets
Few changes in other organs were observed on histopathology.
There was mild to moderate gross enlargement of tracheobron-
chial lymph nodes with microscopic lesions of moderate follicular
hyperplasia as a result of the antigenic stimulation in all ferrets
(both H1N9 and H6N1, days 3 and 7 pi). Perivascular cuffs of
lymphocytes were present in the olfactory nerves and olfactory
bulbs of the brain for one of the two ferrets infected with H6N1 on
day 7 pi and one of the two ferrets infected with H1N9 on day
7 pi, although no influenza antigen was detected via immunohis-
tochemistry on day 3 pi in the olfactory bulb for any of the ferrets.
However, these lesions in combination with positive virus isolation
on olfactory bulb in one of the ferrets infected with H6N1 on day
3 pi, are supportive of probable direct extension of virus from the
infected nasal epithelium, as has been shown in numerous
experimental intranasal influenza inoculations (Table 2)
[6,21,38]. Virus isolation was also performed on several other
organs with sporadic positive results for rectal swabs, liver, and
spleen, despite the absence of histopathologic lesions in these
organs (Table 2).
Figure 1. Nasal shedding and direct contact transmission of
wild bird influenza viruses in ferrets. Seven ferrets were
intranasally inoculated with 5610
5 PFUs of either H6N1 (A) or H1N9
(B) and nasal washes were collected and titered on MDCK cells (days
post-inoculation portion of graph). Three naı ¨ve ferrets were paired with
three of the inoculated ferrets 24 hours post inoculation for each virus
group (days post-direct contact portion); nasal washes were collected
titered on MDCK cells. Both H6N1 and H1N9 demonstrated replication
in the upper respiratory tract of the ferrets, however, viral shedding was
consistently greater in magnitude and duration for H1N9. H1N9
demonstrated direct contact transmission, but H6N1 did not transmit
to direct contact ferrets.
doi:10.1371/journal.pone.0038067.g001
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PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e38067Figure 2. Histopathologic lesions and influenza antigen localization in ferrets inoculated with wild bird influenza viruses. A) Nasal
turbinates of ferrets inoculated with H6N1 or H1N9 demonstrated moderate submucosal inflammation (asterisk) (H1N9, d3pi). B) There is widespread
strong intranuclear and some intracytoplasmic positive immunoreactivity for the nucleoprotein of influenza A on immunohistochemistry in ferrets
inoculated with H6N1 or H1N9 on day 3 pi (H1N9, d3pi). C) Epithelial damage in the lung was early for ferrets inoculated with H1N9, with necrosis in
the bronchioles (arrow) and inflammation (asterisks) within and around bronchioles on day 2 pi. D and E) There was evidence of early repair with
regeneration of bronchiolar epithelium (arrow) and persistence of inflammation (asterisks) on day 3 pi for ferrets inoculated with H6N1 and H1N9
(H1N9, d3pi). The arrow highlights the stretched and plump bronchiolar epithelial cells, indicating regeneration. F) Presence of influenza antigen was
confirmed in ferrets inoculated with H6N1 andH 1 N 9b ys t r o n gp o s i t i v ei n t r a n u c l e a rs t a i n ing of bronchiolar epithelial cells with
immunohistochemistry on day 3 pi (H6N1, d3pi). G) Inflammation around larger airways in the lung was also present in ferrets inoculated with
H6N1 and H1N9, with prominent periglandular bronchial inflammation (asterisk) (H6N1, d7pi). H) There was strong positive intranuclear staining for
the nucleoprotein of influenza in the peribronchial glandular epithelial cells on immunohistochemistry on day 3 pi in ferrets inoculated with H6N1
and H1N9 (H1N9, d3pi).
doi:10.1371/journal.pone.0038067.g002
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e38067Wild bird H1N9 influenza virus transmitted via contact
between ferrets
Interestingly, H1N9 exhibited contact transmission between
ferrets consistently in all three ferret pairs, but H6N1 did not
directly transmit (Figure 1). All three direct contact ferrets that
became infected with H1N9 had similar peak viral titers (average
peak of 5.2 log10 TCID50 for transmission ferrets and average peak
of 5.4 log10 TCID50 for inoculated ferrets) with similar length of
shedding time (5 days for both groups) in the nasal wash compared
to inoculated ferrets, although the time point of transmission
varied greatly between pairs. Transmission variability may be
somewhat explained by the varied time point of peak virus in the
inoculated ferrets, which matched the pattern of transmission to
the paired direct contact ferret (e.g. the later the peak virus in the
inoculated ferret, the later the paired contact ferret had indication
of transmission). Again, in ferrets that were infected via direct
contact transmission, ferret health including clinical signs and
morbidity parameters (temperature/weight loss) were minimally
affected (Table 1). Direct contact transmission of H1N9 was
repeated with a second study, and subsequently confirmed by two
out of three direct contact ferrets becoming infected (data not
shown).
Wild bird influenza viruses exhibited typical AIV receptor
specificity
Effective transmission by the H1N9 virus raised questions
regarding potential mechanisms for transmission. Segment four,
encoding the HA gene was sequenced for each virus to examine
receptor specificity as compared to HA sequences defined in the
literature. Both H6N1 and H1N9 viruses contained glutamic acid
(E) and glycine (G) at positions 190 and 225 of the HA, in contrast
to human influenza strains, A/North Carolina/1/1918 and A/
Pennsylvania/08/2008, that contains aspartic acid (D) at both 190
and 225 position (Table 3) that is associated with to a2,6 linked
sialic acid receptor specificity [39,40]. The glutamine (Q) at
position 226 and glycine (G) at position 228 of the HA are
characteristic of avian strains but have been also been identified in
human strains and have been shown to influence a2,3 linked sialic
acid receptor specificity. The H1N9 and H6N1 viruses contained
the HA amino acid residues most commonly present in avian
influenza strains that exhibit a2,3 linked sialic acid specificity.
To functionally assess the sialic acid receptor specificity of
H1N9 and H6N1, we examined the erythrocyte binding of the
avian influenza strains. Both viruses were able to agglutinate
equine erythrocytes to a 512 HAU/ml titer (Table 4), while the
human influenza strains (A/New Caledonia/20/1999 and A/
California/04/2009) generated no detectable titer. Red blood cells
(RBCs) from most species express both a2,3 and a2,6 linked sialic
acids, but equine erythrocytes are unique in that they exhibit
predominantly a2,3 linked SA receptors. Both H6N1 and H1N9
agglutinated guinea pig and turkey RBCs to similar levels as
compared to a human influenza. Turkey erythrocytes contain
a mixture of a2,3 and a2,6 linked sialic acid linked receptors and
guinea pig RBCs express largely a2,6 linked sialic acids with lower
levels of a2,3 linked sialic acid receptors [41]. While the mixed
a2,3 and a2,6 linkages on these RBCs precludes determination of
definitive a2,6 linked sialic acid binding, the lack of clear changes
in binding to erythrocytes expressing predominantly a2,6 linked
sialic acids suggests limited binding to these glycans.
To further define the receptor specificity of the viruses, glycan
microarrays were utilized to determine the precise sialyl-oligosac-
charide binding profile for H1N9 and H6N1 as compared to
a previously defined seasonal H1N1 human influenza virus, A/
Pennsylvania/08/2008 [40]. Purified and fluorescently labeled
viruses were submitted to Core H of the Consortium for
Functional Glycomics and binding was assessed against 511
glycans (Table S2). The binding motif for all three viruses shows
that the H1N9 and H6N1 predominantly bind oligosaccharides
that contain N-acetylneuraminic acid a2,3 moieties with little
binding observed for the a2,6 and a2,8 linked sialic acid
containing glycans (Fig. 3A,B). There was limited N-glyconeur-
aminic acid (NeuGc) recognition for the H1N9 and H6N1 with
only the a2,3 NeuGc glycans demonstrated binding. The NeuGc
moieties are the predominant sialic acid species on equine
erythrocytes, where the H1N9 and H6N1 a2,3 NeuGc SA
binding preference corroborates the horse erythrocyte agglutina-
tion data (Table 4) [42]. In contrast, the human control strain (A/
Pennsylvania/08/2008) demonstrated the predicted a2,6 linked
sialic acid receptor binding properties (Fig. 3C) with minor a2,3
linked sialic acid binding, which is common among human
influenza viruses. This uncharacteristic a2,3 linked sialic acid
receptor specificity is often the result of fucosylated and sulfated
modifications to the oligosaccahrides enhancing suboptimal sialic
acid receptor recognition, which, as previously shown, appears to
be the case for the human control strain (A/Pennsylvania/08/
2008) [40].
Discussion
It has been demonstrated that some low pathogenic H6, H7,
and H9 AIV subtypes have the ability to replicate in ferrets;
however studies that have demonstrated this examined primarily
poultry adapted isolates and have limited scope in examining the
Table 2. Presence of influenza virus in ferret organs by virus isolation in ECEs for ferrets infected with wild bird avian influenza
viruses H6N1 and H1N9.
Virus Days post inoculation Lung Rectal swab Intestine Olfactory bulb Liver Spleen
H6N1 3 2/2 2/7 0/2 1/2 1/2 0/2
5N D
a 1/5 ND ND ND ND
7 0/2 0/5 ND ND ND ND
H1N9 3 2/2 1/7 0/2 0/2 2/2 1/2
5 ND 1/5 ND ND ND ND
7 0/2 1/5 ND ND ND ND
For each organ listed, the number of animals with a positive isolation of virus out of the number of animals tested is shown.
aNot done for this sample.
doi:10.1371/journal.pone.0038067.t002
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[43] demonstrated that a two H1N1 AIVs isolated a ducks and
a mallard could infect ferrets and replicate to high titers in the
upper respiratory tract of ferrets. We have previously shown that
current circulating North American wild bird LPAIVs do have
a capacity to infect and replicate in mammals using a mouse model
of infection, although they caused little or no disease [19]. More
recently, Nam et al [37] identified an H6N5 isolated from a fecal
sample of an aquatic bird in Korea, A/AB/Kor/CN5/09 (H6N5),
that infected mice, replicated to high titer and caused mortality
without adaptation. Interestingly, this virus also disseminated to
extrapulmonary tissues. From the previous work we selected two
viruses of distinct subtype for further study in the ferret model,
which most accurately emulated human infection and transmission
of influenza virus [44–46]. We have expanded upon previous work
by demonstrating that subtypes of ‘‘lesser concern’’ isolated from
migratory shore birds (i.e. Ruddy Turnstone) can also directly
infect and replicate in mammals, even with the potential for direct
contact mammal to mammal transmission (Table 1, Figure 1). In
the study by Nam et al the A/AB/Kor/CN5/09 (H6N5) virus also
replicated to high titers in the upper respiratory tract of ferrets and
caused middle disease. Similar to our findings with the H1N9
virus, the H6N5 virus showed limited transmission to contact
naı ¨ve ferrets [37]. Interestingly, the PB1 segment of the H6N5
virus was similar to and possibly derived from the H5N1 highly
pathogenic avian influenza viruses circulating in Asia. In contrast,
comparison of the sequences from the AIVs described here
demonstrates that the segments are all of LPAIV origin, unrelated
to HPAI viruses (data not shown). The H6N5 virus was isolated
from feces, and so the species of origin is unknown. It would be
interesting to identify the potential reservoirs of this virus through
live bird surveillance.
Our viruses were passaged in embryonated chicken eggs, which
may lend to some adaptive mutations; however, we kept serial
passages low to minimize alteration of the original viruses.
Interestingly, these viruses replicated to relatively high titers in
the upper respiratory tract of the ferret and induced lesions in both
the upper and lower respiratory tracts, but minimal disease was
observed clinically with complete resolution of pulmonary lesions
(Table 1, Figures 1–2). Importantly, lesions and antigen localiza-
tion in the lung indicate there was no alveolar replication of the
virus. Alveolar localization of influenza with alveolar lesions has
been associated with increased virulence [47]. Additionally, the
results of virus titration and histopathology comparing days 2 and
3 pi is supportive that infection was rapid, minimal, and had rapid
clearance in the lower respiratory tract. These observations may
have played a role in the minimal induction of disease for these
two viruses in the ferret. A study that examined a variety of AIVs
of the H6 subtype not only demonstrated replication with variable
morbidity in ferrets, but also showed no correlation between the
ability to infect the ferrets and the source of the virus (e.g. wild bird
vs. poultry) [7]. This study provides additional indication that the
source of virus may not be as important of a factor in transmission
to mammals, regardless of subtype, although many other factors
would play a role in natural transmission including host
interactions and amount of virus shed.
Avian influenza virus infections and H7 infectious in particular
have presented as conjunctivitis [2]. While this route of
administration is understudied in ferrets, Belser et al [48] recently
explored infection of ferrets with human influenza viruses and
avian influenza viruses isolated from human infections. Both
Table 3. Comparison of critical amino acids involved in receptor specificity of influenza hemagglutinin.
Hemagglutinin Amino Acids
a
Virus Isolate ID HA Subtype Host 190 225 226 228 Accession No.
A/Ruddy Turnstone/DE/1171/2002 H1N9 H1 Avian E G Q G CY116631
A/Ruddy Turnstone/DE/892/2002 H6N1 H6 Avian E G Q G CY116633
A/Duck/Alberta/35/1976 H1 Avian E G Q G AF091309
A/South Carolina/1/1918 H1 Human D D Q G AF117241
A/New Caledonia/20/1999 H1 Human N D Q G AB304818
A/Pennsylvania/08/2008 H1 Human D D Q G FJ549047
A/California/04/2009 H1 Human D D Q G FJ966082
aHemagglutinin residues using H3 numbering.
doi:10.1371/journal.pone.0038067.t003
Table 4. Agglutination of erythrocytes from different animal species by human and avian influenza viruses.
Hemagglutination Titers
a
Virus Isolate ID HA Subtype Host Turkey Equine Guinea Pig
A/Ruddy Turnstone/DE/1171/2002 H1N9 H1 Avian 1024 512 512
A/Ruddy Turnstone/DE/892/2002 H6N1 H6 Avian 1024 512 256
A/New Caledonia/20/1999 H1 Human 1024 0 256
A/California/04/2009 H1 Human 64 0 16
A/Pennsylvania/08/2008 H1 Human 128 0 32
aHemagglutination titers are provide as the reciprocal of the highest virus dilution generating agglutination.
doi:10.1371/journal.pone.0038067.t004
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H3, H5, and H7, and HPAI and LPAI types could infect via the
ocular route and spread to the pulmonary tract. Interestingly, the
H7 influenzas transmitted to naı ¨ve contact ferrets [48]. We did not
explore ocular infection in this study; however in light of the
demonstrated infection and transmission with H7 influenza
viruses, this should be an area of future study.
Figure 3. Glycan binding analysis of wild bird avian or human influenza viruses. Influenza viruses were propagated in Madin-Darby kidney
cells, purified on a 25% sucrose cushion by ultracentrifugation, and labeled with Alexa488 before being applied to the microarray. The data was
organized based on Neu5GC, a2,3 SA, a2,6 SA and a2,8 SA glycan structures and represented by different color schemes. Glycan microarray binding
analysis was performed by Core H of the Consortium for Functional Glycomics. A) A/Ruddy Turnstone/DE/1171/02 (H1N9), B) A/Ruddy Turnstone/DE/
892/02 (H6N1), C) A/Pennsylvania/08/2008 (H1N1).
doi:10.1371/journal.pone.0038067.g003
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rapid to resolve regardless of magnitude of virus and pulmonary
lesions. This rapid transient infection may be related to inoculation
methods, which place a large dose of virus in an anesthetized ferret
where it becomes inhaled deep into the respiratory tract. This
confounds risk assessment, as natural exposure would be through
a fomite or aerosol droplet from another infected individual. Early
pulmonary viral titers and histopathology have not been examined
in transmission ferrets in other transmission experiments or in this
study. This would be an interesting component to evaluate to aid
in determining the pulmonary replication capacity of these AIVs
in a more realistic transmission setting.
Few studies have examined hematologic parameters in in-
fluenza infected ferrets, but investigation into this is worthy as it
may be a good measure of clinical disease [49]. Examining clinical
pathologic findings of such a small sample size can be difficult,
given the marked variation between individuals. Nonetheless,
there was a trend in both groups H6N1 and H1N9 compared to
the allantoic inoculated group of a decrease in lymphocytes on day
1 pi that resolved by day 3 pi for individual animals. Lymphope-
nia is well established to occur in the very early stages of viral
infections. Indeed, it has been demonstrated that experimental
ferret infections with HPAI H5N1 viruses result in a profound
lymphopenia days 3 and 5 pi [50]. Also, ferrets infected with
a variety of H1N1 influenza viruses had a decrease in lymphocytes
days 3 and 7 pi [49]. For H1N9 inoculated animals, lymphocytes
were increased between days 7 pi through 18 pi for many
individuals. Lymphocytosis has not been described in ferrets
experimentally infected with influenza, although this finding seems
logical, given that chronic antigenic stimulation can induce
increases in lymphocytes resulting in peripheral lymphocytosis.
Infectivity of AIVs in mammals and humans is thought to be
reliant on the viral hemagglutinin binding sialic acid (SA) residues
on host cells, and differences in binding between mammalian
versus avian influenza viruses are suggested to be partially
responsible for host specificity and localization of infection
[24,51]. It is thought that the avian influenza preference for
binding a2,3 linked SA receptors compared to the human
influenza preference for binding a2,6 linked SA receptors provides
somewhat of a barrier to transmission in ferrets and humans due to
the paucity of a2,3 linked SA in the upper respiratory tract.
However, there is a presence of a2,3 linked SA in the lower
respiratory tract of both these species, and it has been proposed
that if enough influenza can be deposited in the lower respiratory
tract, pulmonary infection will predominate in these species [47].
We did observe infection and replication in the lung of these
ferrets for both H6N1 and H1N9 that supports viral attachment in
the lung (bronchioles, but not alveoli), however, we also observed
robust upper respiratory tract infections that were more pro-
ductive with higher viral titers present than compared to the lung
despite the alpha a2,3 SA binding preference (Table 1, Figures 1–
2).We and others typically observe that ferrets infected with
human influenza viruses have viral replication restricted to the
upper respiratory tract [52–54]. The absence of pulmonary
infection is confirmed by negative virus isolation, absence of
lesions on histopathology, and absence of viral antigen on IHC.
Very mild pulmonary infections have been demonstrated in other
laboratories with human influenza viruses in experimental ferret
infections, however severe pneumonia is only associated with
highly virulent human influenza viruses or highly pathogenic avian
influenza viruses [38,47,55]. In this study, neither H6N1 nor
H1N9 virus appeared to infect alveolar epithelial cells (Figure 2)
yet, both viruses did infect mouse and feline alveolar epithelial cells
in other in vivo experimental trials in our laboratory (submitted and
[19]). Other experiments have demonstrated replication of AIVs
in the upper and lower respiratory tract of ferrets with some
viruses having higher replication in the nasal turbinates and others
with higher replication in the lung [6,7,21]. Clearly, cellular
tropism in an influenza infected host is complex, and while the
cellular SA ligand for HA binding is certainly an important
component, additional mechanisms are likely at work.
In our study, the H1N9 subtype AIV exhibited efficient direct
contact transmission between ferrets. Aerosol transmission was not
explored in this study due to lack of a validated aerosol
transmission model in our facilities, however, it would be an
interesting next step. Many experiments have established the
importance of receptor binding in influenza transmission, dem-
onstrating limited or no contact or aerosol transmission in viruses
that have a binding preference for a2,3 linked SA over a2,6 linked
SA [10,43,56,57]. Both the H1N9 and H6N1 viruses have avian
specific a 2,3 linked SA receptor binding as shown in the
erythrocyte binding assays. There are no previously defined HA
amino acid residues that would suggest an altered receptor
specificity and this assumption is supported by the glycan
microarray analysis, where H1N9 dominantly bound glycans
having a2,3 SA linkages. However, there may be other un-
identified amino acids in the HA or other viral gene segments that
mediated the efficient direct transmission of the H1N9 in ferrets,
where other H1N1 viruses failed to efficiently transmit via contact
[43]. Direct contact H6N1 ferrets did not become infected and did
not seroconvert (Figure 1). Perhaps this is due to lower levels of
viral shedding for a shorter period of time in H6N1 infected ferrets
as compared to H1N9 infected ferrets.
The viral polymerase has also been suggested to potentially have
a role in efficient avian to mammalian transmission, replication,
and localization of viral infection based upon differences in
temperature for optimal replication, tissue/species tropism for
replication, rate of replication, and effect on efficiency of viral
nuclear transport [43,58–64]. Sequence analysis of H1N9 PB2
found avian specific Glu627 and Asp701 residues (GenBank
Accession ACY79819; data not shown), suggesting that there may
be other genetic features contributing to the robust upper
respiratory replication and transmission of this H1N9 virus in
ferrets.
Our study, in combination with additional studies of AIV
infections in ferrets, indicates that there is a capacity for wild bird
AIVs, subtype notwithstanding, to directly infect mammals with
minimal clinical signs. The results support the potential for direct
interspecies transmission or formation of a viable AIV reassortant.
Although we have demonstrated the low virulence and rapid
clearance of these AIVs, possibilities for reassortment in suscep-
tible wild and domestic mammalian species make these species of
particular interest and worth further investigation. Furthermore,
the variable magnitude of seroconversion despite productive
influenza infection could make surveillance and monitoring for
mammalian infection with AIVs difficult. Together, these studies
support the need for expanded analysis of influenza viruses from
their reservoir species as understanding of the mechanisms of
infection and transmission is incomplete and subsequent risk
assessment imperfect.
Materials and Methods
Ethics statement
These studies were conducted in strict accordance with
guidelines approved by the Institutional Animal Care and Use
Committee and supported through the Office of Animal Care and
use of the University of Georgia, following guidelines established
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Accreditation of Laboratory Animal Care; Accreditation Date:
3/2/2011), licensed by the USDA (USDA #57-R-005), and
maintaining an Assurance of Compliance with the U.S. De-
partment of Health and Human Services (PHS Assurance
#A3437-01). The protocols utilized for these studies were
approved by the Institutional Animal Care and Use Committees
of the University of Georgia and the Centers for Disease Control
and Prevention.
Viruses
Avian influenza viruses used were cloacal swab isolates from
wild birds in the United States acquired from Southeastern
Cooperative Wildlife Disease Study (Athens, GA). Viruses were
isolated from cloacal swabs in 9 day old embryonated chicken eggs
(ECE) at 37uC for 72 hours and then minimally passaged (3 or
fewer passages) in ECEs. Select virus isolates were screened in
a previous study in BALB/c mice [19]. Two viruses that exhibited
efficient pulmonary replication and induced pulmonary lesions in
BALB/c mice were selected for in vivo studies in ferrets: A/Ruddy
Turnstone/DE/892/02 (H6N1 subtype; NCBI Taxonomy ID:
680602; abbreviated H6N1) and A/Ruddy Turnstone/DE/1171/
02 (H1N9 subtype; NCBI Taxonomy ID: 680596; abbreviated
H1N9). The original low passage isolates, once selected by
screening methods, were grown once more in 9 to 10 day old
ECE to generate a stock of the virus. Stock viruses were aliquoted
and stored at 280uC until use. Stock virus titers were determined
by plaque assay on MDCK cells.
Sequencing
Total viral RNA was extracted from AIV infected allantoic fluid
using the RNeasy kit (QIAGEN, Inc., Valencia, CA) according to
the manufacturer’s protocol. One-step RT-PCR was performed
on viral RNA using a universal primer set (Uni12/Inf-1 59-
GGGGGGAGCAAAAGCAGG-39 and Uni13/Inf-1 59-
CGGGTTATTAGTAGAAACAAGG-39) as previously described
[65]. All 8 segments were generated, the HA segment was excised
and gel purified using the QIAquick Gel Extraction kit (QIAGEN,
Inc., Valencia, CA). The HA was sequenced using BigDye
Terminator v3.1 Cycle Sequencing kit (Applied Biosystems) with
subtype specific primers (primer sequences available upon re-
quest). Some sequences for the H1N9 and H6N1 viruses were
already available on GenBank. The accession numbers are
GU050646.1, GU050647.1, GU050624.1, GU050623.1,
GU050622.1, GU050620.1, GU050619.1, GU050618.1, and
GU050621.1 (A/ruddy turnstone/Delaware/892/2002 segment
1 and segment 2, and A/ruddy turnstone/Delaware/1171/2002
segments, 1, 2, 3, 5, 6, 7, and 8 respectively). HA sequences are
available at GenBank. Segments sequenced for this study and
submitted to GenBank include A/ruddy turnstone/Delaware/
892/2002 segments 3, 4, 6, and 8 and A/ruddy turnstone/
Delaware/1171/2002 segment 4 (GenBank Accession numbers
CY116632, CY116633, CY116634, CY116633, and CY116631,
respectively).
Erythrocyte binding assays
Fresh turkey, guinea pig, and equine erythrocytes were
thoroughly washed with 16 PBS and resuspended to 1% v/v in
16 PBS/.5%BSA. A standard hemagglutination assay was
performed for each AIV isolate against all types of erythrocytes,
and appearance of agglutination was scored after a 60-min
incubation period.
Glycan microarray binding
Viruses were cultured at an MOI of 0.01 on MDCKs for
72 hours in 16 Minimal Essential Medium supplemented with
1 mg/ml TPCK [L-(tosylamido-2-pheyl) ethyl chloromethyl ke-
tone]-treated trypsin (Worthington Biochemical Corporation,
Lakewood, NJ). The viral supernatant (10 ml) was collected and
centrifuged at 5,000 RPM for 5 minutes to remove cell debris
before viral purification. Virus in the culture supernatant was
purified on a 25% sucrose cushion and resuspended in 16 PBS
with 1 mM EDTA. Briefly, each virus was purified through a 25%
sucrose gradient by high speed centrifugation at 28,000 rpm at
4uC for 3 hours. The purified viruses were resuspended in1XPBS
with 1 mM EDTA on ice for 4 hours and stored at 280uC. Viral
titers were determined by standard plaque assay on MDCK cells.
Approximately 10
7 PFU of each purified strain were labeled with
25 mg of Alexa488 dye in 1 M NaHCO3 (pH 9) for 1 hour. To
remove residual dye, each sample was dialyzed in a 7000 MWCO
Slide-A-Lyzer MINI dialysis cassette (Thermo Scientific) against
PBS with 1 mM EDTA overnight. The labeled viruses were
analyzed via glycan microarray by the Core H of the Consortium
of Functional Glycomics (www.functionalglycomics.org), where
70 ml of labeled virus was added to glycan microarray slide and
incubated at 4uC for 1 hour. Each microarray was scanned by
Perkin-Elmer ProScanAray that detected SA binding peaks
designated as relative fluorescent units (RFUs).
Ferrets
Castrated male Fitch ferrets (Triple F Farms, Sayre, PA), 3
months old and seronegative to circulating human H1N1 and
H3N2 influenza viruses, were used for the study. Ferrets were
housed in a BSL2 facility in HEPA filtered isolator caging
(Allentown, Allentown, NJ). A subcutaneous temperature tran-
sponder (BMDS, Seaford, DE) was implanted in each ferret for
identification and temperature measurement.
Infection and direct transmission study
Seven ferrets were inoculated per virus (four for tissue
examination and three for transmission study) and three additional
naive ferrets were used to assay direct contact transmission. In the
contact trials, one direct contact ferret was housed with one
inoculated ferret as paired cage mates. An additional three ferrets
were mock infected with allantoic fluid in PBS for negative
controls for nasal washes, serology, and complete blood counts
(CBC). Inoculated ferrets were lightly anesthetized with isoflurane
and intranasally inoculated with 5610
5 PFU in 500 mL of sterile
PBS (250 mL of per nostril) with either H6N1 or H1N9. Direct
contact ferrets were placed with inoculated ferrets twenty-four
hours post inoculation. An additional study was performed with
H1N9 as previously described to confirm direct contact trans-
mission, using three inoculated and three direct contact ferrets.
Temperatures monitored for four days to establish baseline then
temperature, weights, and complete blood counts were monitored
in inoculated ferrets on days 1, 3, 5, 7, 10, 13, 18, and 21 pi and in
direct contact ferrets on days 2, 4, 6, 9, 12, 17, and 20 post contact
(pc). Nasal washes were sampled from ferrets on days 1, 3, 5, 7,
10 pi or days 2, 4, 6, 9, 12, and 17 pc to monitor for viral
infection. For nasal washes, ferrets were anesthetized with 4 mg
ketamine via intramuscular injection and 1 mL of sterile PBS with
penicillin (4000 U/ml) (Calbiochem, Gibbstown, NJ), streptomy-
cin (800 mg/ml) (Sigma, St. Louis, MO), polymyxin B (400 U/ml)
(MP Biochmemicals, LLC, Solon, OH), and gentamicin (100 mg/
ml) (Gibco, Carlsbad, CA) was introduced into the nostrils to
induce sneezing and collected in specimen cups. For repeat study
ferrets, temperature, weights, and nasal washes were performed for
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13 and 15 pi and on days 2, 4, 6, 8, 10, 12, and 14 pc. Repeat
study ferrets were humanely euthanized at day 21 pi (day 20 pc)
and samples of lung from all ferrets were fixed in neutral buffered
formalin for histopathology.
Determination of viral titers
Nasal washes were immediately tested via real time RT-PCR to
aid in determining days for sample collection. Briefly, viral RNA
was extracted from nasal wash by using RNeasy mini kit
(QIAGEN, Inc., Valencia, CA) and the Qiagen one-step RT-
PCR kit was used for RRT-PCR with a Stratagene MX300P/
3005P thermocyler and Mx Pro QPCR software (La Jolla, CA).
Reaction mixture and PCR cycling protocol is available upon
request. An influenza virus matrix gene specific primer and probe
set were used as follows: primer M+25, sequence AGA TGA GTC
TTC TAA CCG AGG TCG; primer M-124, sequence TGC
AAA AAC ATC TTC AAG TCT CTG; and probe M+64,
sequence FAM-TCA GGC CCC CTC AAA GCC GA-TAMRA
[66] (Biosearch Technologies, Novato, CA).
Four ferrets per virus were humanely euthanized (two on day
3 pi and two on day 7 pi per virus) and lung, nasal turbinate, liver,
spleen, and olfactory bulb were sampled under sterile conditions
and frozen at 280uC for virus isolation. Based on histopathology
and viral titers from the lung, we suspected early pulmonary
infection with rapid clearance, therefore an additional two ferrets
were intranasally inoculated as previously described with H1N9
and humanely euthanized at day 2 pi with fresh lung collected to
examine the earlier time point. Tissues were later homogenized in
1 mL PBS with antibiotics, clarified by centrifugation, and 100 mL
of clarified homogenate was inoculated into 9 to 10 day old ECEs
for virus isolation (4 eggs per sample, 72 hour incubation). Nasal
washes and clarified lung homogenate were titrated in MDCK
cells with serial 1:10 or 1:3 dilutions with a 1.5 log10TCID50/mL
(nasal wash) and 1. 3 to 1.0 log10 TCID50/gram (lung).
Serology and hematology
At day 21 pi (day 20 pc), blood was collected and seroconver-
sion was determined via hemagluttination inhibition (HI) and
microneutralization (MN) assays. All blood samples were analyzed
the same day as sample collection. Complete blood counts were
performed using VetScan analyzer (Abaxis, Union City, CA).
Leukocyte counts were log transformed and statistically analyzed
using repeated measures ANOVA (Stata version 11.0) to examine
differences between viral groups and days pi. Degrees of freedom
for F-tests of repeated measures factors were adjusted using the
Greenhouse-Geisser estimate of epsilon to correct for any
departures from the sphericity assumption. All testing assumed
a two-sided alternative hypothesis and P-values,0.05 were
considered significant.
Histopathology and immunohistochemistry
Lung (cranial and caudal lobes), trachea, tracheobronchial
lymph node, esophagus, heart, spleen, liver, stomach, small
intestine, large intestine, pancreas, mesenteric lymph node,
kidneys, adrenal gland, bladder, brain, and nasal turbinates were
collected on days 3 and 7 pi from inoculated ferrets (two ferrets
per virus per day, the same ferrets as described for virus isolation
in fresh tissues). The additional two ferrets that were intranasally
inoculated with H1N9 and humanely euthanized at day 2 pi had
the same set of tissues collected for histopathology and immuno-
histochemistry. All tissues were preserved in 10% neutral buffered
formalin. Tissues were routinely processed, embedded and stained
with hematoxylin and eosin. Immunohistochemical staining was
performed on lung, trachea, and nasal turbinates for all ferrets.
Immunohistochemistry was performed using a commercially
available goat polyclonal antibody to the nucleoprotein of
influenza A virus at a 1:10,000 dilution (Biodesign International,
Sako, Maine). Tissues were deparaffinized and blocked with
a commercial protein blocking agent (Dako Cytomation, Carpin-
teria, CA) and a linked strepavidin-biotin immunoperoxidase
system was used for immunolabeling. The reaction was visualized
with 3, 39-diaminobenzidine substrate (Dako Cytomation, Car-
pinteria, CA).
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